bioecon Member area
Suppliers · Producer · Industrial biotech & bio-based materials

Enzymaster 酶赛生物

Enzymaster provides custom biocatalytic manufacturing and R&D services, utilizing its proprietary BioEngine and BioNavigator platforms to develop innovative, sustainable enzyme technologies. It serves clients in the pharmaceutical, fine chemical, food, cosmetics, and materials industries by offering solutions ranging from early-stage enzyme discovery and engineering to industrial-scale production.

active ChinaAsia Founded 2013 checked 2026-10-05

Profile

Enzymaster (Ningbo) Bio-Engineering Co., Ltd. is a China-based biotechnology company specializing in biocatalysis, synthetic biology, and enzyme engineering for the production of pharmaceutical intermediates, food additives, and fine chemicals. Founded in 2013 and headquartered in Ningbo, the company provides integrated solutions ranging from R&D to industrial-scale manufacturing.

Core technology includes the proprietary BioEngine directed evolution platform and the BioNavigator computational toolbox, which utilize AI and high-throughput sequencing to optimize enzyme performance. The company has transitioned from a service-oriented model to a product-driven enterprise, commercializing over 20 products including intermediates for drugs like ezetimibe and sacubitril.

Enzymaster is active as of 2026 and has initiated an IPO process, with plans to complete Pre-IPO financing in the first half of 2026 at an estimated valuation exceeding 1.5 billion CNY. The company has raised over 300 million CNY in cumulative funding through Series C, with investors including YuanBio Venture Capital, Puhua Capital, and Kangjun Investment. It maintains international operations through a business unit in Düsseldorf, Germany, and serves global clients including AstraZeneca, Bayer, and Merck.

Sources#

Industry
Biorefining, Digital & robotics, Energy, Industrial chemistry
Topics
Enzymes & biocatalysis
Role
Producer — “…rom R&D to industrial-scale manufacturing [1][3]. Core technology includes the proprietary BioEngine directed…”

Bio-solutions it supplies 1

What they offer

Products: 酶供应; 定向进化; 酶工程; 酶优化; 计算机辅助酶定向进化; 生物催化; 绿色化学; 发酵; 可再生资源; 酶筛选

Sites 5

  • Ningbo Biochemical products
  • Zhejiang Province, Ningbo City, Zhenhai District
  • International business unit, Düsseldorf, Germany
  • Fermentation pilot plant, Ningbo, China
  • Locations in Singapore

Key manufacturing facilities, pilot plants, and R&D centers compiled from regulatory disclosures and corporate filings.

Applications
Pharmaceutical engineering · Fine chemicals · New materials · Biological industry · Energy-saving and environmental protection industry · Biocatalytic custom synthesis services
Customers & partners
酶赛 · 定向进化 · 酶工程 · 酶优化 · 计算机辅助酶定向进化 · 生物催化 · 绿色化学 · 发酵 · 可再生资源 · 酶筛选 · 高通量筛选 · 生物信息学
Products (website)
酶供应 · 定向进化 · 酶工程 · 酶优化 · 计算机辅助酶定向进化 · 生物催化 · 绿色化学 · 发酵 · 可再生资源 · 酶筛选 · 高通量筛选 · 生物信息学
R&D facilities
Enzymatic technology platform

Read from the company's own website: home · about · products · production · rnd · contact · description · description · description

Subsidiaries: 酶赛生化 (Enzymaster Biochemical) · Enzymaster Deutschland GmbH

Status

  • 2026-02 Latest status: The company announced the official launch of its IPO in early 2026. ↗ ↗ ↗

Recent news 5

Curated from verified corporate disclosures and market announcements. Review original publications for complete commercial details.

Network: owners, partners, peers

Ownership & investors 1

subsidiary酶赛生化

Partners & deals 1

joint ventureSino-foreign joint venture established
…commodity chemicals, and consumer goods ingredients. Company highlights: - Sino-foreign joint venture established in 2013 in Ningbo with ~130 employees. - Headquarters near Shanghai; Germany…

Similar companies

Bontac Bio-Engineering (Shenzhen) Co., Ltd · SyncoZymes · Amano Enzyme · EnzymeWorks, Inc. · Revelations Biotech Pvt. Ltd. · VTR Biotech · Bestzyme · Advanced Enzyme Technologies Limited

Company facts

Registry identifiers

  • Unified Social Credit Code: 91330200079226140E

Sources: aiqicha.baidu.com

Funding

  • Latest round: Series c · 2022-01-24 · US$ 47.4 M
  • Total raised: US$ 54.7 M

Commercial milestones and operating metrics compiled from corporate filings, press disclosures, and registry data. Registration numbers should be cross-referenced with official state registers.

Identity & contacts

Contacts, people and legal identity are available to members.

Sign in as a member